Mercer Global Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
3,013
+41
| +1% | +$6.22K | ﹤0.01% | 1579 |
|
|
2025
Q1 | $447K | Buy |
2,972
+521
| +21% | +$78.4K | ﹤0.01% | 1534 |
|
|
2024
Q4 | $452K | Sell |
2,451
-1,907
| -44% | -$352K | ﹤0.01% | 1504 |
|
|
2024
Q3 | $846K | Buy |
4,358
+327
| +8% | +$63.5K | ﹤0.01% | 1078 |
|
|
2024
Q2 | $833K | Buy |
4,031
+1,721
| +75% | +$356K | ﹤0.01% | 1052 |
|
|
2024
Q1 | $626K | Buy |
2,310
+210
| +10% | +$56.9K | ﹤0.01% | 1156 |
|
|
2023
Q4 | $497K | Buy |
2,100
+143
| +7% | +$33.8K | ﹤0.01% | 1333 |
|
|
2023
Q3 | $384K | Buy |
1,957
+287
| +17% | +$56.3K | ﹤0.01% | 1386 |
|
|
2023
Q2 | $351K | Sell |
1,670
-234
| -12% | -$49.2K | ﹤0.01% | 1414 |
|
|
2023
Q1 | $384K | Buy |
1,904
+230
| +14% | +$46.4K | ﹤0.01% | 1349 |
|
|
2022
Q4 | $365K | Sell |
1,674
-30
| -2% | -$6.54K | ﹤0.01% | 1390 |
|
|
2022
Q3 | $335K | Sell |
1,704
-77
| -4% | -$15.1K | ﹤0.01% | 1343 |
|
|
2022
Q2 | $381K | Buy |
1,781
+223
| +14% | +$47.7K | ﹤0.01% | 1297 |
|
|
2022
Q1 | $442K | Sell |
1,558
-1,248
| -44% | -$354K | ﹤0.01% | 1292 |
|
|
2021
Q4 | $1.06M | Buy |
2,806
+583
| +26% | +$220K | 0.01% | 858 |
|
|
2021
Q3 | $917K | Sell |
2,223
-18
| -0.8% | -$7.43K | 0.01% | 896 |
|
|
2021
Q2 | $829K | Buy |
2,241
+1,485
| +196% | +$549K | 0.01% | 918 |
|
|
2021
Q1 | $219K | Buy |
+756
| New | +$219K | ﹤0.01% | 1439 |
|